Skip to main content
Sign In
 

Cardiology - Research Funding


 

(listed alphabetically by Principal Investigator or by Section faculty member involved)

Usefulness of the Cardio-Pulmonary Interactions in the Appraisal and the Hemodynamic Management of Pediatric Patients on Mechanical Ventilation
Principal Investigator: Eduardo M. da Cruz, MD
Source: University Hospital of Geneva
Amount: $15,000/yr
Term: 2006 - 2009

Modifying Dietary Behavior in Adolescents with Elevated Blood Pressure
Principal Investigator: Sara Couch, PhD, RN
Co-Investigator: Stephen R. Daniels, MD, PhD
Source: University of Cincinnati - R01 HL088567
Amount: $245,701
Term: 2008 - 2009

SEARCH for Diabetes in Youth 2: Ohio Center
Principal Investigator: Lawrence Dolan, MD
Co-Investigator: Stephen R. Daniels, MD, PhD
Source: NIH - U01 DP000248
Amount: $459,513
Term: 2006 - 2010

Childhood Precursors for Adulthood Metabolic Syndrome
Principal Investigator: Shumei Sun, PhD, FAHA
Co-Investigator: Stephen R. Daniels, MD, PhD
Source: Virginia Commonwealth University - R01 DK071485-02
Amount: $333,595
Term: 2007 - 2008

Clinical Proteomics Center in Lung Disease+
Principal Investigator: Frank J. Accurso, MD
Source: NHLBI, NIH - U01HL081335-01
Amount: $4,216,147
Term: 2005 - 2009

  • Core A: Administrative
    Principal Investigator: Frank J. Accurso, MD
    Amount: $453,886
  • Core B: Clinical
    Principal Investigator: Steven H. Abman, MD
    Co-Investigators: John P. Kinsella, MD, and D. Dunbar Ivy, MD
    Amount: $862,397
  • Core C: Data Management
    Principal Investigator: Gary O. Zerbe, PhD
    Amount: $884,826
  • Core D: Laboratory
    Principal Investigator: Mark W. Duncan, PhD
    Amount: $1,251,968
  • Core E: Educational
    Principal Investigator: Laurie A. Shroyer, PhD
    Co-Investigator: Robin R. Deterding, MD
    Amount: $604,993

Sildenafil in Treatment of Sickle Cell Disease-Associated Pulmonary Hypertension
Principal Investigator: David Badesch, MD
Co-Investigator: D. Dunbar Ivy, MD
Source: NHLBI, NIH - HHSN268200617185C
Amount: $250,000
Term: 2006 - 2009

SCCOR Grant: Lung Vascular Disease in Infants and Children: Mechanisms and Treatment*
Principal Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - P50 HL084923
Amount: $12,345,967
Term: 2006 - 2011

  • Project 1: Noninvasive Inhaled NO in Premature Newborns
    Principal Investigator: John P. Kinsella, MD
    Co-Investigator: Steven H. Abman, MD
    Amount: $2,457,532
  • Project 3: Advanced Imaging and Diagnostics for Pediatric Pulmonary Hypertension
    Principal Investigators: Robin Shandas, PhD, and D. Dunbar Ivy, MD
    Amount: $2,271,467
  • Project 4: Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling
    Principal Investigator: Kurt R. Stenmark, MD
    Co-Investigators: Maria Frid, PhD, and Eva N. Grayck, MD
    Amount: $2,038,122
  • Project 5: Hypoxia-Inducible Factors in Neonatal Pulmonary Hypertension
    Principal Investigator: Carl W. White, MD
    Co-Investigators: Aftab Ahmad, PhD, Steven H. Abman, MD, and Theresa R. Grover, MD
    Amount: $2,686,424
  • Core A: Administrative Core
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $531,250
  • Core B: Noninvasive Inhaled Nitric Oxide in Premature Newborns
    Principal Investigator: Ling-Yi Chang, MD
    Co-Investigator: Steven H. Abman, MD
    Amount: $795,448
  • Core C: Clinical Research Skills Development Core
    Principal Investigator: Steven H. Abman, MD
    Amount: $531,222

Cardiac Cell-Specific Determinants of Reovirus Myocarditic Potential
Principal Investigator: Shelley D. Miyamoto, MD
Source: TCH Research Institute
Amount: $70,000/yr
Term: 2007 - 2009

Transdermal Absorption and Blood Level of Opioids in Swine
Principal Investigator: Suzanne M. Osorio-Lujan, DVM
Source: Anesthesia Department., University Hospital of Geneva, Switzerland
Amount: $25,000 chf
Term: 2006 - 2009

Development of a Micro- and Macro-Particle Image Velocimetry System for Opaque Flows
Principal Investigator: Robin Shandas, PhD
Source: Chemical and Transport Systems, National Science Foundation - 0421461
Amount: $499,936
Term: 2005 - 2008

Development of a Noninvasive Flow Velocimetry System for Opaque Flows
Principal Investigator: Robin Shandas, PhD
Source: National Science Foundation, Major Research Instrumentation Development Award
Amount: $138,000
Term: 2004 - 2007

Multi-Scale Modeling and Imaging in Pediatric PHT
Principal Investigator: Robin Shandas, PhD
Collaborators: Neil Davie, PhD, Karrie L. Dyer Villavicencio, MD, Ruchira Garg, MD, D. Dunbar Ivy, MD, and Lilliam M. Valdes-Cruz, MD
Source: NHLBI, NIH, Bioengineering Research Partnerships
Amount: $2,762,414
Term: 2005 - 2010

Noninvasive Assessment of Pediatric Pulmonary Hypertension
Principal Investigator: Robin Shandas, PhD
Co-Investigator: D. Dunbar Ivy, MD
Source: NHLBI, NIH - 5R01-HL067399-03
Amount: $900,000
Term: 2001 - 2006

Noninvasive Diagnostics in Pulmonary Hypertension
Mentor: Robin Shandas, PhD
Source: NHLBI, NIH - K25
Amount: $75,000/yr
Term: 2008 - 2013

T32 Graduate Training in Cardiovascular Biomechanics and Imaging
Principal Investigator: Robin Shandas, PhD
Faculty Collaborator: Curt DeGroff, MD
Source: NHLBI, NIH - T32 HL 72738
Amount: $850,000
Term: 2003 - 2008

Endothelial Function in Patients with Marfan Syndrome: A Pilot Investigation
Principal Investigator: Angela T. Yetman, MD
Study Coordinator: Amy L. Taylor, MS
Source: TCH Research Institute
Amount: $26,300
Term: 2003 - 2007

Study of Dexamethasone in Neonatal Lupus CHB
Principal Investigator: Jill Buyon, MD
Collaborator: Karrie L. Dyer Villavicencio, MD
Source: NIH - 5R01AR046265-05
Amount: $1,978,608
Term: 2000 - 2006


+ Supporting research funding in Neonatology, Pediatric Heart Lung Center, and Pulmonology
* Supporting research funding in Critical Care Medicine, Neonatology, Pediatric Heart Lung Center, Perinatal Research Center, Pulmonology, and the Center for Bioengineering

Infant Heart Transplantation from Non-Heart Beating Donors: A Strategy to Reduce Waiting Mortality
Principal Investigator: Mark M. Boucek, MD
Co-Investigators: Biagio A. Pietra, MD, David N. Campbell, MD, D. Dunbar Ivy, MD, and Shelley D. Miyamoto, MD
Source: US Department of Health and Human Services, Health Resources and Services Administration - 1R38OT01314-01-00
Amount: $591,009
Term: 2003-2006

Molecular Epidemiology of Dilated Cardiomyopathy
Principal Investigator: Luisa Mestroni, MD
Co-Investigators: Mark M. Boucek, MD, and Jean L. Cavanaugh, MS, PA-C
Source: National Institutes of Health - 1R01 HL96071-01
Amount: $494,290
Term: 2001-2005

Adventitial Vasa Vasorum Neovascularization Contributes to the Pathogenesis of Pulmonary Hypertension
Principal Investigator: Neil Davie, PhD
Source: American Heart Association - 0560061Z
Amount: $132,000
Term: 2005-2006

Antihypertensive Therapy in Autosomal Dominant Polycystic Kidney Disease
Principal Investigator: Robert W. Schrier, MD
Co-Investigator: Curt G. DeGroff, MD
Source: National Institutes of Health - 5 RO1 DK058793
Amount: $1,493,027
Term: 2001-2006

Study of Dexamethasone in Neonatal Lupus CHB
Principal Investigator: Jill Buyon, MD
Collaborator: Karrie L. Dyer, MD
Source: National Institutes of Health - 5R01AR046265-05
Amount: $1,978,608
Term: 2000-2006

Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases
Co-Investigator: D. Dunbar Ivy, MD
Source: I-NO Therapeutics
Term: 2001-present

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study of Intravenous Sildenafil in the Treatment of Children, Age 0 to 17 Years with Pulmonary Hypertension After Corrective Cardiac Surgery
Co-Investigator: D. Dunbar, Ivy, MD
Source: Pfizer, Inc.
Term: 2003-present

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Age 1-16 Years, with Pulmonary Arterial Hypertension
Co-Investigator: D. Dunbar Ivy, MD
Source: Pfizer, Inc.
Term: 2003-present

A Phase III Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium Treatment with an Open-Label Bosentan Arm in Patients with Pulmonary Arterial Hypertension
Co-Investigator: D. Dunbar Ivy, MD
Source: Encysive Pharmaceuticals, Inc.
Term: 2003-present

A Double-Blind Safety and Efficacy Study of Sitaxsentan Sodium Treatment in Patients with Pulmonary Arterial Hypertension Who Have Failed Bosentan Therapy
Co-Investigator: D. Dunbar Ivy, MD
Source: Encysive Pharmaceuticals, Inc.
Term: 2003-present

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients with Pulmonary Arterial Hypertension
Co-Investigator: D. Dunbar Ivy, MD
Source: Encysive Pharmaceuticals, Inc.
Term: 2003-present

A Double-Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Iloprost in Combination with Bosentan in Subjects
Co-Investigator: D. Dunbar Ivy, MD
Source: Exhale Therapeutics, Inc.
Term: 2003-present

Clinical Proteomics Center in Lung Disease (Core B)
Principal Investigator: Frank J. Accurso, MD
Co-Investigators: D. Dunbar Ivy, MD, and John P. Kinsella, MD
Source: National Institutes of Health, National Heart, Blood and Lung Institute - U01-HL081335
Amount: $908,829
Term: 2005-2009

Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
Principal Investigator: Joseph D. Kay, MD
Co-Investigator: D. Dunbar Ivy, MD
Source: Sanofi-Synthelabo
Term: 2005-2006

Carvedilol Study
Principal Investigator: Biagio A. Pietra, MD
Co-Investigator: Shelley D. Miyamoto, MD
Source: University of Utah - SB105517-321
Amount: $100,000
Term: 2000-2005

The Mechanism of CD4 T-Cell Dependent Acute Cardiac Allograft Rejection
Principal Investigator: Biagio A. Pietra, MD
Source: National Institutes of Health - 5 R01 HL067976-03
Amount: $1,125,000
Term: 2001-2005

Noninvasive Assessment of Pediatric Pulmonary Hypertension
Principal Investigator: Robin Shandas, PhD
Co-Investigator: D. Dunbar Ivy, MD
Source: National Institutes of Health, National Heart, Blood and Lung Institute - 5R01-HL067399-03
Amount: $900,000
Term: 2001-2006

T32 Graduate Training in Cardiovascular Biomechanics and Imaging
Principal Investigator: Robin Shandas, PhD
Faculty Collaborator: Curt DeGroff, MD
Source: National Institutes of Health, National Heart Lung and Blood Institute - T32 HL 72738
Amount: $850,000
Term: 2003-2008

Sodium Restriction and Arterial Compliance in Older Humans
Principal Investigator: Doug Seals, PhD
Co-Investigator: Robin Shandas, PhD
Source: National Institutes of Health, National Institute on Aging - RO1
Amount: $300,000
Term: 2000-2005

Real Time Blood Flow Velocimetry Using Ultrasound
Principal Investigator: Robin Shandas, PhD
Source: National Institutes of Health, National Heart, Lung, and Blood Institute - R21
Amount: $175,000
Term: 2004-2006

Development of an Ultrasound-Based Micro-Flow Imaging System for Biomedical Applications
Principal Investigator: Robin Shandas, PhD
Source: National Science Foundation - EECS-0225405
Amount: $150,000
Term: 2002-2005

Acquisition of a Particle Image Velocimetry System
Principal Investigator: Jean Herztberg, PhD
Co-Investigator: Robin Shandas, PhD
Source: National Science Foundation
Amount: $150,000
Term: 2002-continuing

Development of a Noninvasive Flow Velocimetry System for Opaque Flows
Principal Investigator: Robin Shandas, PhD
Source: National Science Foundation, Major Research Instrumentation (MRI) Development Award
Amount: $138,000
Term: 2004-2007

Advanced Pulse Sequence Development for Cardiovascular Flow Quantitation Using MRI
Principal Investigator: Robin Shandas, PhD
Source: Siemens MRI Imaging Inc.
Amount: $100,000
Term: 2004-continuing

Effect of Flow on TGF Expression from Endothelial Cells
Principal Investigator: Kristina Rinker, PhD
Co-Investigator: Robin Shandas, PhD
Source: The Whitaker Foundation
Amount: $73,000
Term: 2002-2005

Multi-Scale Modeling and Imaging in Pediatric PHT
Principal Investigator: Robin Shandas, PhD
Collaborators: Neil Davie, PhD, Karrie Dyer, MD, Ruchira Garg, MD, D. Dunbar Ivy, MD, and Lilliam M. Valdes-Cruz, MD
Source: National Institutes of Health, National Heart, Lung, and Blood Institute, Bioengineering Research Partnerships
Amount: $2,762,414
Term: 2005-2010

Development of SMPs for Cardiovascular Application
Principal Investigator: Robin Shandas, PhD
Source: National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering - R21
Amount: $150,000
Term: 2005-2007

Nanoparticles and Nanobubbles for Molecular Imaging in Diabetes
Principal Investigator: Conrad Stoldt, PhD
Co-Investigator: Robin Shandas, PhD
Source: The Butcher Foundation
Amount: $76,000
Term: 2005-2006

Shape Memory Polymers for Endovascular Stents
Principal Investigator: Robin Shandas, PhD
Source: University of Colorado Technology Transfer Office
Amount: $10,000
Term: 2006-2006

Cardiac Synagis/Numax Study
Co-Investigator: Henry M. Sondheimer, MD
Study Coordinator: Kristy Rahimi-Alangi, MS
Source: MedImmune, Inc.
Amount: $100,000
Term: 2005-2006

Assessment of the Effect of Sildenafil on Aerobic Capacity and Pulmonary Artery Pressure Estimates in Patients with Cystic Fibrosis and Pulmonary Hypertension
Principal Investigator: Steven H. Abman, MD
Co-Investigator: Angela T. Yetman, MD
Source: Pfizer, Inc.
Amount: $43,496
Term: 2004-2005

Endothelial Function in Patients with Marfan's Syndrome: A Pilot Investigation
Principal Investigator: Angela T. Yetman, MD
Study Coordinator: Amy L. Taylor, MS
Source: The Children's Hospital Research Institute
Amount: $26,300
Term: 2003-2007

Infant Heart Transplantation from Non-Heart-Beating Donors: A Strategy to Reduce Waiting Mortality
Principal Investigator: Mark M. Boucek, MD
Source: US Department of Health and Human Services, Health Resources and Services Administration - 1R38OT01314-01-00
Amount: $590,000
Term: 2003-2006

Molecular Epidemiology of Dilated Cardiomyopathy
Principal Investigator: Luisa Mestroni, MD
Co-Investigators: Mark M. Boucek, MD, and Jean Lascor, MS, PA-C
Source: National Institutes of Health - 1R01 HL96071-01
Amount: $494,290
Term: 2001-2006

Carvedilol Study
Principal Investigator: Mark M. Boucek, MD
Co-Investigator: Jean Lascor, MS, PA-C
Source: University of Utah - SB105517-321
Amount: $100,000
Term: 2000-2005

Prospective Study of Dexamethasone in Neonatal Lupus Congenital Heart Block - Aim 1, Aim 2, Aim 2a
Principal Investigator: Jill Buyon, MD
Co-Investigator: Curt G. DeGroff, MD
Source: Hospital for Joint Diseases - 1R01Ar046265-10A1
Amount: $1,978,608
Term: 2002-2003

Antihypertensive Therapy in Autosomal Dominant Polycystic Kidney Disease
Principal Investigator: Robert W. Schrier, MD
Co-Investigator: Curt G. DeGroff, MD
Source: National Institutes of Health - 5 R01 DK058793
Amount: $1,493,027
Term: 2001-2006

Development of a Cardiac Screening Device Using Artificial Neural Networks
Principal Investigator: Curt G. DeGroff, MD
Source: American Heart Association - 0256013Z
Amount: $110,000
Term: 2002-2004

Phase I: Development of a Cardiac Screening Device
Consultant: Curt G. DeGroff, MD
Source: National Institutes of Health, Small Business Innovative Research
Amount: $100,000
Term: 2003-2004

Role of Endothelium in Perinatal Pulmonary Vasoregulation**
Principal Investigator: D. Dunbar Ivy, MD
Source: National Institutes of Health - 5K08 HL03823
Amount: $508,432
Term: 1999-2003

Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases
Co-Investigator: D. Dunbar Ivy, MD
Source: iNO Therapeutics
Term: 2001-present

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study of Intravenous Sildenafil in the Treatment of Children, Aged 0 to 17 Years with Pulmonary Hypertension After Corrective Cardiac Surgery
Principal Investigator: D. Dunbar, Ivy, MD
Source: Pfizer, Inc.
Term: 2003-present

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-16 Years, with Pulmonary Arterial Hypertension
Principal Investigator: D. Dunbar Ivy, MD
Source: Pfizer, Inc.
Term: 2003-present

A Phase III Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium Treatment with an Open-Label Bosentan Arm in Patients with Pulmonary Arterial Hypertension
Principal Investigator: D. Dunbar Ivy, MD
Source: Encysive
Term: 2003-present

A Double-Blind Safety and Efficacy Study of Sitaxsentan Sodium Treatment in Patients with Pulmonary Hypertension Who Have Failed Bosentan Therapy
Principal Investigator: D. Dunbar Ivy, MD
Source: Encysive
Term: 2003-present

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients with Pulmonary Arterial Hypertension
Principal Investigator: D. Dunbar Ivy, MD
Source: Encysive
Term: 2003-present

A Double-Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Iloprost in Combination with Bosentan in Subjects
Principal Investigator: D. Dunbar Ivy, MD
Source: Exhale Therapeutics
Term: 2003-present

The Mechanism of CD4 T Cell Dependent Acute Cardiac Allograft Rejection
Principal Investigator: Biagio A. Pietra, MD
Source: National Institutes of Health - 5 R01 HL067976-03
Amount: $1,125,000
Term: 2001-2005

Prospective Assessment After Pediatric Cardiac Ablation (PAPCA)
Principal Investigator: Michael S. Schaffer, MD
Source: National Heart, Blood and Lung Institute - R01-HL58620-01A1
Amount: $28,500
Term: 1999-2003

Noninvasive Assessment of Pediatric Pulmonary Hypertension
Principal Investigator: Robin Shandas, PhD
Source: National Institutes of Health, National Heart, Blood and Lung Institute - 5R01-HL067399-03
Amount: $900,000
Term: 2001-2005

T32 Graduate Training in Cardiovascular Biomechanics and Imaging
Principal Investigator: Robin Shandas, PhD
Faculty Collaborator: Curt G. DeGroff, MD
Source: National Institutes of Health, National Heart, Blood and Lung Institute
Amount: $850,000
Term: 2003-2008

Sodium Restriction and Arterial Compliance in Older Humans
Principal Investigator: Doug Seals, PhD
Co-Investigator: Robin Shandas, PhD
Source: National Institutes of Health, National Institute on Aging - R01
Amount: $250,000
Term: 2000-2004

Development of a Noninvasive Method to Estimate Pulmonary Vascular Resistance in Pediatric Pulmonary Hypertension
Principal Investigator: Robin Shandas, PhD
Source: American Heart Association, National Chapter - 0151364Z
Amount: $225,000
Term: 2001-2003

Real-Time Blood Flow Velocimetry Using Ultrasound
Principal Investigator: Robin Shandas, PhD
Source: National Institutes of Health, National Heart, Lung, and Blood Institute - R21
Amount: $175,000
Term: 2004-2006

Development of an Ultrasound-Based Micro-Flow Imaging System for Biomedical Applications
Principal Investigator: Robin Shandas, PhD
Source: National Science Foundation - EECS-0225405
Amount: $150,000
Term: 2002-2004

Acquisition of a Particle Image Velocimetry System
Principal Investigator: Jean Herztberg, PhD
Co-Investigator: Robin Shandas, PhD
Source: National Science Foundation
Amount: $150,000
Term: 2002-ongoing

Development of a Noninvasive Flow Velocimetry System for Opaque Flows
Principal Investigator: Robin Shandas, PhD
Source: National Science Foundation, Major Research Instrumentation (MRI) Development Award
Amount: $138,000
Term: 2004-2007

Noninvasive Assessment of Prosthetic Heart Valve Function
Principal Investigator: Robin Shandas, PhD
Source: American Heart Association, Desert/Mountain Affiliate
Amount: $110,000
Term: 2001-2003

Advanced Pulse Sequence Development for Cardiovascular Flow Quantitation Using MRI
Principal Investigator: Robin Shandas, PhD
Source: Siemens MRI Imaging Inc.
Amount: $100,000
Term: 2004-ongoing

Effect of Flow on TGF Expression from Endothelial Cells
Principal Investigator: Kristina Rinker, PhD
Co-Investigator: Robin Shandas, PhD
Source: The Whitaker Foundation
Amount: $73,000
Term: 2002-2005

Biomechanics of Pediatric Pulmonary Hypertension
Principal Investigator: Robin Shandas, PhD
Source: March of Dimes Birth Defects Foundation
Amount: $70,000
Term: 2001-2004

Development of a Remote Telemetry System for Noninvasive Evaluation of Prosthetic Heart Valve Function In Vivo
Principal Investigator: Robin Shandas, PhD
Source: Colorado Commission on Higher Education/Colorado Alliance for Bioengineering
Amount: $56,000
Term: 2002-2003

Development of Noninvasive Methods to Quantify Prosthetic Valve Function: In Vitro Studies
Principal Investigator: Robin Shandas, PhD
Source: American Heart Association, Desert/Mountain Affiliate
Amount: $50,000
Term: 2001-2003

Pulmonary Reactivity in the Neonatal Hypoxic Calf Model
Principal Investigator: Janice Bright, DVM
Co-Investigator: Robin Shandas, PhD
Source: Colorado State University Research Program
Amount: $34,000
Term: 2002-2003

Filtration Efficiency of a Depth Distal-Protection Filter
Principal Investigator: Robin Shandas, PhD
Source: POSSIS Inc.
Amount: $20,000
Term: 2004

Synagis Prophylaxis Against RSV Infections for Infants with Congenital Heart Disease
Principal Investigator: Henry M. Sondheimer, MD
Source: MedImmune, Inc.
Amount: $120,000
Term: 1998-2003

Assessment of the Effect of Sildenafil on Aerobic Capacity and Pulmonary Artery Pressure Estimates in Patients with Cystic Fibrosis and Pulmonary Hypertension
Principal Investigator: Steven H. Abman, MD
Co-Investigator: Angela T. Yetman, MD
Source: Pfizer, Inc.
Amount: $43,496
Term: 2004-2005


** Supporting research funding in the Pediatric Heart Lung Center

Head CT in the Evaluation of 1st Afebrile Seizures
Principal Investigator: Lalit Bajaj, MD, MPH
Co-Investigators: Mark G. Roback, MD, Louis C. Hampers, MD, MBA, Carol Okada, MD, and Rebecca Fastle, MD
Term: 2000-2004

Postreduction Management of Intussusception
Principal Investigator: Lalit Bajaj, MD, MPH
Co-Investigators: Mark G. Roback, MD, and Shayne Bland, MSc
Term: 2000-2002

Emergency Medical Services for Children Partnership Grant
Principal Investigator: F. Keith Battan, MD
Source: US Department of Health and Human Services, Maternal and Child Health Bureau -
FLAEMS01-00250
Amount: $122,000
Term: 2000-2001

L.O.C.O. (Latinos Overcoming Cultural Obstacles) "Needs Assessment for The Children's Hospital"
Principal Investigator: Sonja Burbano-O'Leary, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Source: Colorado Chapter of the American Academy of Pediatrics
Amount: $3,000
Term: 2001

The Truth about Language Barriers
Principal Investigator: Sonja Burbano-O'Leary, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Stephen Federico, MD
Source: Colorado Chapter of the American Academy of Pediatrics
Amount: $3,000
Term: 2001-ongoing

Jungle Mobile: A Mobile Injury Prevention Project for Children
Principal Investigator: Kathryn D. Emery, MD
Co-Investigators: Allison Hawkes, MD, MS, Theresa Rapstine, RN, and Victoria Cassenbaugh, RN
Term: 1998-ongoing

A Screening Tool for the Detection of Child Abuse in the Emergency Department Setting
Joint Project with the Child Advocacy Protection Team

Principal Investigator: Kathryn D. Emery, MD
Term: 2001

Seat Belt and Car Safety Seat Use in SUVs
Primary Investigator: Kathryn D. Emery, MD
Co-Investigators: Lisa Hardin Van Bramer, MD, and Kevin Raines, MD
Source: National Highway Traffic Safety Administration - STNH22-01-H-05-257
Amount: $350,000
Term: 2001-2003

Childhood Injury Prevention Concerns of Migrant and Seasonal Farm Workers in Weld County
Principle Investigator: Kathryn D. Emery, MD
Co-Investigator: S. Glenn Faries, MD
Source: Colorado Injury Control Research Center
Amount: $15,000
Term: 2002-2003

Domestic Violence Policies in Pediatric Emergency Departments
Principle Investigator: Kathryn D. Emery, MD
Co-Investigators: Sheila Sullivan, MD, Andrew P. Sirotnak, MD, and Stephanie Stronks-Knapp, MD
Term: 2002-ongoing

Development of an Injury-Free Coalition for Kids
Principal Investigator: S. Glenn Faries, MD
Co-Investigator: Kathryn D. Emery, MD
Term: 2001-ongoing

Resident Education in the Emergency Department
Principal Investigator: S. Glenn Faries, MD
Term: 2002-ongoing

Need for Atropine for Emergent Pediatric Intubations
Principal Investigator: Rebecca Fastle, MD
Co-Investigator: Mark G. Roback, MD
Term: 1999-ongoing

Resuscitation Teaching at Primary Care Centers
Principal Investigator: Margaret Ferguson, MD
Co-Investigator: Mark G. Roback, MD
Term: 1998-ongoing

Utility of Anaerobic Blood Cultures in a Pediatric Emergency Department
Principal Investigator: Stephen Freedman, MD
Co-Investigator: Genie E. Roosevelt, MD, MPH
Term: 2001-2003

PEM Collaborative Research Committee, Cerebral Edema and DKA
Principal Investigator: Nicole Glaser, MD
Co-Investigator: Mark G. Roback, MD
Term: 1998-2001

Comparison of Oral Prednisone vs. Dexamethasone in Pediatric Asthma
Principal Investigator: Richard A. Greenberg, MD
Co-Investigators: Genie E. Roosevelt, MD, MPH, and Gwendolyn S. Kerby, MD
Term: 2002-ongoing

Peak Flow vs. Spirometry in Acute Asthma
Principal Investigator: David Gutglass, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 1997-ongoing

A.C.C.E.S.S. for Latinos: After-Hours Call Center and Extended Spanish Service
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: Lauren Clark, PhD, RN, and Stephen Berman, MD
Term: 2001-2002

The Impact of Interpreters on Resource Utilization in a Pediatric Emergency Department
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigator: Jennifer McNulty, MD
Term: 1999-2002

Physician-Based Practice Pattern Variations in the Management of AGE
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigator: Elizabeth Powell, MD, MPH
Term: 2001-ongoing

Practice Variation in the Management of Croup
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: S. Glenn Faries, MD, and Steven R. Poole, MD
Term: 1999-2002

Regional After-Hours Urgent Care Provided by a Tertiary Children's Hospital
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: S. Glenn Faries, MD, and Steven R. Poole, MD
Term: 2001-2002

Booster Seat Project
Principal Investigator: Lisa Hardin Van Bramer, MD
Co-Investigator: Kathryn D. Emery, MD
Source: Emergency Medical Services and Kiwanis Pediatric Trauma Institute
Amount: $18,000
Term: 2001-2002

Association of Influenza with Bacterial Tracheitis
Principal Investigator: Ron L. Kaplan, MD
Co-Investigators: Mark G. Roback, MD, and Peggy Kelly, MD
Term: 2002-ongoing

Safety, Tolerability and Efficacy Study of Levalbuterol and Racemic Albuterol in Pediatric Patients Birth to 48 Months Old with Reactive Airways Disease in an Acute Setting
Principal Investigator: Gwendolyn S. Kerby, MD
Co-Investigator: S. Glenn Faries, MD
Term: 2001-2002

Effect of Ondansetron on Ketamine Sedation-Associated Vomiting
Principal Investigator: William T. Langston, MD
Co-Investigators: Joseph E. Wathen, MD, and Mark G. Roback, MD
Source: The Children's Hospital Research Institute
Amount: $5,000
Term: 2002-ongoing

Effect of Medical Spanish Classes on Satisfaction of Hispanic Patients in Pediatric Emergency Department
Principal Investigator: Suzanne Mazor, MD
Co-Investigators: Vidya Chande, MD, Louis C. Hampers, MD, MBA, and Steven Krug, MD
Term: 2000-2002

Interpretation of Traumatic Lumbar Punctures: Who Can Go Home?
Principal Investigator: Suzan Mazor, MD
Co-Investigators: Jennifer McNulty, MD, and Genie E. Roosevelt, MD, MPH
Term: 2001-ongoing

How Is Emergency Department Decision-Making Affected by the Existence of Reliable Follow-Up?
Principal Investigator: Jennifer McNulty, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Steven Krug, MD
Term: 1999-2001

Decision Rules for Obtaining Radiographs in Pediatric Knee Injuries
Principal Investigator: Brian Moore, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Kathryn Emery, MD
Term: 1998-ongoing

Indications for Knee Radiographs in Pediatric Patients with Acute Knee Injuries/Validation of a Clinical Decision Rule
Principal Investigator: Brian Moore, MD
Co-Investigators: Carol Turner, MD, and Kathryn D. Emery, MD
Term: 2000-ongoing

Correlation of Hemolysis with Facticous Hyperkalemia
Principal Investigator: Heather Owens, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing

Acute Complication of Type 1 Diabetes in Children
Primary Investigator: Arleta B. Rewers, MD, PhD
Co-Investigators: Mark G. Roback, MD, and Joan P. Bothner, MD
Term: 2001-ongoing

Childhood Pedestrian Injuries
Primary Investigator: Arleta B. Rewers, MD, PhD
Term: 2002-ongoing

Femur Fractures and Associated Injuries
Principal Investigator: Arleta B. Rewers, MD, PhD
Co-Investigators: Kathryn D. Emery, MD, and F. Keith Battan, MD
Term: 2000-ongoing

Are Chest X-Rays Required for all First-Time Wheezers?
Principal Investigator: Mark G. Roback, MD
Co-Investigators: Mark E. Anderson, MD, and John D. Strain, MD
Term: 1998-ongoing

Comparison of the Efficacy and Safety of Sedation Drugs Used in a Pediatric Emergency Department
Principal Investigator: Mark G. Roback, MD
Co-Investigators: Joseph E. Wathen, MD, and Joan P. Bothner, MD
Term: 1999-ongoing

IV vs. IM Ketamine Sedation in the Pediatric Emergency Department
Principal Investigator: Mark G. Roback, MD
Co-Investigator: Joseph E. Wathen, MD
Source: The Children's Hospital Research Institute
Amount: $35,000
Term: 2000-ongoing

Pediatric Resuscitation Practice and Success Rate
Principal Investigator: Mark G. Roback, MD
Co-Investigator: Rebecca Fastle, MD
Term: 2000-ongoing

Predictors of Which Patients will Benefit from Observations vs. Hospital Admission
Principal Investigator: Genie E. Roosevelt, MD, MPH
Co-Investigator: S. Glenn Faries, MD
Term: 2002-ongoing

Randomized, Double-Blind Study of Intravenous Fluids With and Without Dextrose in the Treatment of Dehydration in Pediatric Patients with Vomiting and Ketosis
Principal Investigator: Genie E. Roosevelt, MD, MPH
Term: 2002-ongoing

The Effect of Dehydration on the QT Interval of Healthy Children
Principal Investigator: Carl Shaw, MD
Co-Investigators: Joseph E. Wathen, MD, and Michael S. Schaffer, MD
Term: 2001

The Prevalence of Urinary Tract Infections in Febrile Children with AGE
Principal Investigator: Carl Shaw, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing

Use of Complementary Medicine in Pediatric Patients with Asthma
Principal Investigator: Alison Siegel Tothy, MD
Co-Investigator: Genie E. Roosevelt, MD, MPH
Term: 2001-2002

Associations between Insurance Type and Pediatric Admission Rate in Colorado, 1993-1999: Is Managed Care Fulfilling Its Promise?
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Jill Joseph, MD, PhD, and James K. Todd, MD
Term: 2000-ongoing

Associations of Parental Depression and Child Health Outcomes
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Allison Kempe, MD, John Steiner, MD, David Price, MD, and David Magid, MD
Term: 2002-ongoing

Comparison of the Longitudinal Marginal Cost, Morbidity and Mortality of Inflicted and Unintentional Head Injuries in Young Children in a Nationwide Sample of Children's Hospitals
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Anne Libby, PhD
Term: 2001-ongoing

Costs of Childhood Physical Abuse: Comparing Inflicted and Unintentional Head Injuries in Colorado Inpatients Under Three Years Old
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Anne Libby, PhD
Term: 2001-ongoing

Epidemiology of Pediatric Psychiatric Visits to US Emergency Departments, Based on the National Hospital Ambulatory Medical Care Survey 1995-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Hospital-Level Predictors of Inefficiency Amongst Hospitalized Patients in New York State
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Jill Joseph, MD, PhD, and Andrew Racine, MD, PhD
Term: 2000-ongoing

Management of Acute Gastroenteritis Visits to Emergency Departments Based on the National Hospital Ambulatory Medical Care Survey, 1995-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Management of Bronchiolitis Visits to Emergency Departments Based on the National Hospital Ambulatory Medical Care Survey, 1993-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Comparison of Fascia Iliaca Compartment Nerve Block to Traditional Systemic Analgesics for Femur Fractures in a Pediatric Emergency Department
Principal Investigator: Joseph E. Wathen, MD
Co-Investigators: Glen Merritt, MD, Gaia Georgopoulos, MD, and F. Keith Battan, MD
Source: The Children's Hospital Research Institute
Amount: $17,594
Term: 2001-2004

Pediatric EKG Interpretation Accuracy by Pediatric Emergency Medicine Physicians
Principal Investigator: Joseph E. Wathen, MD
Co-Investigators: Arleta Rewers, MD, PhD, Angela Yetman MD, and Michael Schaffer MD
Term: 2001-ongoing

A Randomized Trial of Telephonic vs. On-Site Language Interpretation in a Pediatric ED
Principal Investigator: Ethan S. Wiener, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing